SI0975631T1 - 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands - Google Patents

5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands

Info

Publication number
SI0975631T1
SI0975631T1 SI9830088T SI9830088T SI0975631T1 SI 0975631 T1 SI0975631 T1 SI 0975631T1 SI 9830088 T SI9830088 T SI 9830088T SI 9830088 T SI9830088 T SI 9830088T SI 0975631 T1 SI0975631 T1 SI 0975631T1
Authority
SI
Slovenia
Prior art keywords
oxadiazol
azabicyclo
oct
aryl
derivatives
Prior art date
Application number
SI9830088T
Other languages
English (en)
Slovenian (sl)
Inventor
Samir Jegham
Alistair Lochead
Frederic Galli
Alain Nedelec
Axelle Samson
Thierry Gallet
Original Assignee
Sanofi - Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi - Synthelabo filed Critical Sanofi - Synthelabo
Publication of SI0975631T1 publication Critical patent/SI0975631T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SI9830088T 1997-04-18 1998-04-15 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands SI0975631T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704802A FR2762316B1 (fr) 1997-04-18 1997-04-18 Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
EP98920622A EP0975631B1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4
PCT/FR1998/000754 WO1998047898A1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4

Publications (1)

Publication Number Publication Date
SI0975631T1 true SI0975631T1 (en) 2002-06-30

Family

ID=9506076

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830088T SI0975631T1 (en) 1997-04-18 1998-04-15 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands

Country Status (32)

Country Link
US (1) US6255319B1 (bg)
EP (1) EP0975631B1 (bg)
JP (1) JP2001521542A (bg)
KR (1) KR20010006452A (bg)
CN (1) CN1260794A (bg)
AR (1) AR012458A1 (bg)
AT (1) ATE206424T1 (bg)
AU (1) AU742666B2 (bg)
BG (1) BG64053B1 (bg)
BR (1) BR9808926A (bg)
CA (1) CA2286106A1 (bg)
CO (1) CO4750656A1 (bg)
CZ (1) CZ289154B6 (bg)
DE (1) DE69801905T2 (bg)
DK (1) DK0975631T3 (bg)
EE (1) EE03769B1 (bg)
ES (1) ES2165162T3 (bg)
FR (1) FR2762316B1 (bg)
HU (1) HUP0002456A3 (bg)
IL (1) IL132352A0 (bg)
NO (1) NO995040L (bg)
NZ (1) NZ500396A (bg)
PL (1) PL186894B1 (bg)
PT (1) PT975631E (bg)
RU (1) RU2186066C2 (bg)
SI (1) SI0975631T1 (bg)
SK (1) SK283441B6 (bg)
TR (1) TR199902600T2 (bg)
TW (1) TW502005B (bg)
UA (1) UA57071C2 (bg)
WO (1) WO1998047898A1 (bg)
ZA (1) ZA983257B (bg)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
ATE474577T1 (de) * 2003-03-26 2010-08-15 Merck Sharp & Dohme Bicyclische piperidin-derivate als melanocortin-4 rezeptor-agonisten
AU2004290520A1 (en) * 2003-11-18 2005-06-02 Boehringer Ingelheim International Gmbh Solid pharmaceutical preparation form
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP1758891A2 (en) 2004-06-15 2007-03-07 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
PL2967067T3 (pl) * 2013-03-15 2018-04-30 Monsanto Technology Llc N-,C-Dipodstawione azole do kontroli szkodników nicieniowych
GB201814151D0 (en) 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3294611B2 (ja) * 1991-09-12 2002-06-24 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４レセプター・アンタゴニスト
ATE169015T1 (de) * 1992-02-04 1998-08-15 Eisai Co Ltd Aminobenzoesäure derivate
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
NZ321626A (en) * 1995-11-09 1998-10-28 Synthelabo 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one derivatives for use as 5-ht4 or h3 receptor ligands

Also Published As

Publication number Publication date
TW502005B (en) 2002-09-11
CZ364199A3 (cs) 2000-03-15
EE9900487A (et) 2000-06-15
WO1998047898A1 (fr) 1998-10-29
HUP0002456A3 (en) 2001-03-28
HUP0002456A2 (hu) 2000-12-28
BG103810A (bg) 2000-06-30
NZ500396A (en) 2001-04-27
ZA983257B (en) 1998-10-19
DE69801905D1 (de) 2001-11-08
KR20010006452A (ko) 2001-01-26
AR012458A1 (es) 2000-10-18
RU2186066C2 (ru) 2002-07-27
AU7341598A (en) 1998-11-13
NO995040D0 (no) 1999-10-15
PL336315A1 (en) 2000-06-19
CN1260794A (zh) 2000-07-19
UA57071C2 (uk) 2003-06-16
ES2165162T3 (es) 2002-03-01
TR199902600T2 (xx) 2000-03-21
FR2762316A1 (fr) 1998-10-23
AU742666B2 (en) 2002-01-10
CO4750656A1 (es) 1999-03-31
FR2762316B1 (fr) 1999-12-17
CA2286106A1 (en) 1998-10-29
DE69801905T2 (de) 2002-07-04
PL186894B1 (pl) 2004-03-31
US6255319B1 (en) 2001-07-03
SK142699A3 (en) 2000-05-16
DK0975631T3 (da) 2002-01-28
BR9808926A (pt) 2000-08-01
EP0975631A1 (fr) 2000-02-02
JP2001521542A (ja) 2001-11-06
EP0975631B1 (fr) 2001-10-04
BG64053B1 (bg) 2003-11-28
PT975631E (pt) 2002-03-28
ATE206424T1 (de) 2001-10-15
NO995040L (no) 1999-12-16
EE03769B1 (et) 2002-06-17
IL132352A0 (en) 2001-03-19
CZ289154B6 (cs) 2001-11-14
SK283441B6 (sk) 2003-07-01

Similar Documents

Publication Publication Date Title
IL124364A0 (en) 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2 (3h)-one derivatives for use as 5-ht4 or h3 receptor ligands
HK1034070A1 (en) High affinity ligands for nociceptin receptor orl-1.
GB2220981B (en) Seat hinge.
AP9701076A0 (en) Substituted 6,6-hetero bicyclic derivatives
ZA977011B (en) Muscarinic antagonists.
ZA988078B (en) Substituted oxindole derivatives.
HUP9802433A3 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
EP0470350A3 (en) Multi-spindle machine for drilling, milling or similar works
SG71077A1 (en) 8-Substituted-1,3, 8-triaza-spiro (4.5)decan-4-on derivatives
ZA989204B (en) Halogen substituted tetracyclic tetrahydrofuran derivatives.
SI0975631T1 (en) 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
EP0681583A1 (en) TRICYCLIC HETEROCYCLIC COMPOUNDS AS 5-HT4 RECEPTOR ANTAGONISTS.
ZA975626B (en) Antineurodegenerative ergoline derivatives.
AU2688192A (en) 3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity
AU7658798A (en) 5-phenyl-1,3,4-oxadiazol-2(3h)-one derivatives and their use as 5-ht4 ligands
AU1449997A (en) Diazabicyclo-octane derivatives as 5-ht receptor ligands
DK1133494T3 (da) 8-Azabicyclo[3.2.1]oct-2-en-derivater
AU2178299A (en) 8-azabicyclo(3.2.1)oct-2-ene derivatives as pesticides
AU7322196A (en) Pyrido (3,2,1-ij)-1,3,4-benzoxadiazine
ZA9600758D (en) Idole derivatives as 5-ht receptor antagonist.
ZA926889B (en) 5-HT4 receptor antagonists.
AU1441899A (en) Process for the preparation of 8-azabicyclo(3.2.1)octane derivatives
TW334917U (en) Adjustable multi-spindle drills seat
GB9719193D0 (en) Aryloxyalkylamines as selective 5-ht receptor ligands
ZA984639B (en) 8-Azabicyclo [3.2.1]oct-2-ene and octane derivatives their preparation and use